In a historic move, Colombia bypasses a patent to access a key HIV drug | Health News
Yet, the introduction of dolutegravir into more health programmes depends on two things: how many generic doses the Colombian government buys — and how quickly. “It takes some time for generics to be registered,” said Luz Marina Umbasia, director of the Global Humanitarian Progress Corporation in Colombia. Umbasia explained that…